AVEO Pharmaceuticals Enters Oversold Territory (AVEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of AVEO Pharmaceuticals, Inc. ( AVEO) entered into oversold territory, hitting an RSI reading of 26.3, after changing hands as low as $5.61 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 58.5. A bullish investor could look at AVEO's 26.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of AVEO shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

AVEO Pharmaceuticals, Inc. 1 Year Performance Chart

Looking at the chart above, AVEO's low point in its 52 week range is $5.61 per share, with $14.08 as the 52 week high point — that compares with a last trade of $5.63.

null

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

AVEO Pharmaceuticals (AVEO) Stock Pops on European Licensing Agreement

When Eyeing Small Biotechs, Partnerships Are Huge

When Eyeing Small Biotechs, Partnerships Are Huge

Exelixis Scores Much-Needed Kidney Cancer Study Win to Boost Drug Sales